8P Pharmacokinetic (PK) profile and food effect of RP-3500, a highly potent and specific inhibitor of ataxia telangiectasia and Rad3-related (ATR) protein kinase in patients (pts) with cancer. - Lheureux, S.; Rosen, E.; Lee, E.; Spigel, D.; Højgaard, M.; Fontana, E.; Mettu, N.B.; Carter, L.; Patel, S.; Papp, R.; May, S.; Nejad, P.; et al. (Annals of Oncology, 2022)